The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 1,055,034 | 19,772 | SH | SOLE | 19,772 | 0 | 0 | |||
| ARGEN SE - ADR | SPONSORED ADR | 04016X101 | 3,694,276 | 6,702 | SH | SOLE | 6,702 | 0 | 0 | |||
| ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | 68,639 | 45,456 | SH | SOLE | 45,456 | 0 | 0 | |||
| ASCENDIS PHA-ADR | SPONSORED ADR | 04351P101 | 3,896,618 | 22,576 | SH | SOLE | 22,576 | 0 | 0 | |||
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | 1,265,656 | 48,474 | SH | SOLE | 48,474 | 0 | 0 | |||
| CIDARA THERAPEUTICS INC | COM NEW | 171757206 | 8,746,806 | 179,569 | SH | SOLE | 179,569 | 0 | 0 | |||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 410,392 | 59,650 | SH | SOLE | 59,650 | 0 | 0 | |||
| HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | 1,988,669 | 187,257 | SH | SOLE | 187,257 | 0 | 0 | |||
| INSMED INC | COM PAR $.01 | 457669307 | 3,730,725 | 37,070 | SH | SOLE | 37,070 | 0 | 0 | |||
| JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 2,789,152 | 26,283 | SH | SOLE | 26,283 | 0 | 0 | |||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 945,415 | 75,876 | SH | SOLE | 75,876 | 0 | 0 | |||
| NUVATION BIO INC -CW27 | *W EXP 07/07/2027 | 67080N119 | 24,516 | 90,832 | SH | SOLE | 90,832 | 0 | 0 | |||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 9,418,643 | 1,014,940 | SH | SOLE | 1,014,940 | 0 | 0 | |||
| OCULIS HOLDING AG | ORDINARY SHARES | H5870P102 | 2,071,396 | 106,718 | SH | SOLE | 106,718 | 0 | 0 | |||
| PRAXIS PRECISION MEDICINES I | COM | 74006W207 | 3,115,358 | 74,087 | SH | SOLE | 74,087 | 0 | 0 | |||
| RAPPORT THERAPEUTICS INC | COM | 75383L102 | 227,400 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 2,048,945 | 55,693 | SH | SOLE | 55,693 | 0 | 0 | |||
| SOLENO THERAPEUTICS INC | COM | 834203309 | 5,314,668 | 63,436 | SH | SOLE | 63,436 | 0 | 0 | |||
| SURROZEN, INC. | COM NEW | 86889P208 | 1,519,800 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | |||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 1,121,895 | 485,669 | SH | SOLE | 485,669 | 0 | 0 | |||
| TERNS PHARMACEUTICALS INC | COM | 880881107 | 1,730,213 | 463,864 | SH | SOLE | 463,864 | 0 | 0 | |||
| TOURMALINE BIO INC | COM | 89157D105 | 4,536,075 | 283,682 | SH | SOLE | 283,682 | 0 | 0 | |||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 2,700,730 | 493,735 | SH | SOLE | 493,735 | 0 | 0 | |||
| ULTRAGENYX PHARMACEUTICAL INC | COM | 90400D108 | 865,877 | 23,814 | SH | SOLE | 23,814 | 0 | 0 | |||
| UNICYCIVE THERAPEUTICS INC | COM | 90466Y202 | 300,028 | 62,899 | SH | SOLE | 62,899 | 0 | 0 | |||
| VERASTEM INC | COM NEW | 92337C203 | 624,218 | 150,414 | SH | SOLE | 150,414 | 0 | 0 | |||
| WHITEHAWK THERAPEUTICS INC | COM | 00032Q104 | 6,377,452 | 3,410,402 | SH | SOLE | 3,410,402 | 0 | 0 | |||
| ZYMEWORKS INC | COM | 98985Y108 | 1,049,870 | 83,655 | SH | SOLE | 83,655 | 0 | 0 | |||